Vivian Hunt

Dame
Vivian Hunt
DBE
Headshot of Dame Vivian Hunt in 2022
Born
Vivian Yvonne Hunt

July 1967 (age 56–57)
Cleveland, Ohio
NationalityBritish/American
EducationHarvard College; Harvard Business School
OccupationBusiness Executive
Board member ofHarvard Board of Overseers, Teach First, Black Equity Organisation, The British Museum, The Southbank Centre
SpouseNicholas Basden

Dame Vivian Yvonne Hunt DBE (born July 1967) is a business executive and a recognised advocate for equal opportunities across business and society. She is the Chief Innovation Officer of UnitedHealth Group,[1] which is listed 5th in the Fortune 500.[2] With over 400,000 employees and revenues of $370 billion, UHG is committed to improving healthcare for everyone.[3]

She was named one of the ten most influential black women in Britain by the Powerlist Foundation, and one of the 30 most influential people in the City of London by The Financial Times.[4] In 2018, she was appointed Dame Commander of the Order of the British Empire for "services to the economy and women in business".[5][6] She received the Lifetime Achievement Award from the Strategic Management Society in 2022[7] and the Chartered Management Institute's Gold Medal in 2019.[8]

Previously, she was a Senior Partner at McKinsey & Company, helping global private and public companies improve their strategy, operations and performance. She served as Managing Partner of the UK and Ireland, McKinsey's second largest office from 2013-2020, and led their EMEA Life Sciences practice from 2007-2013.[9]

Hunt has extensive board experience with influential business and charitable groups including BritishAmerican Business,[10] where she was Chair, the Confederation of British Industry,[11] Business in the Community[12] and the Trilateral Commission,[13] amongst others. She is Chair of Teach First,[14] the UK's leading education charity and the Black Equity Organisation,[15] the UK's first national Black civil rights organisation. Hunt is also a Trustee of the British Museum[16] and is on the Southbank Centre[17] Board of Governors.

She is the President-elect of the Harvard Board of Overseers (June 2024-25).[18]

  1. ^ "Dame Vivian Hunt". www.unitedhealthgroup.com. Retrieved 15 April 2024.
  2. ^ "Fortune 500". Fortune. Retrieved 15 April 2024.
  3. ^ "United Health Group Q4 2023 Release" (PDF).
  4. ^ "Future of the City". 31 January 2017.
  5. ^ Hendrickson, W. A.; Ward, K. B. (27 October 1975). "Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin". Biochemical and Biophysical Research Communications. 66 (4): 1349–1356. doi:10.1016/0006-291x(75)90508-2. ISSN 1090-2104. PMID 5.
  6. ^ Chow, Y. W.; Pietranico, R.; Mukerji, A. (27 October 1975). "Studies of oxygen binding energy to hemoglobin molecule". Biochemical and Biophysical Research Communications. 66 (4): 1424–1431. doi:10.1016/0006-291x(75)90518-5. ISSN 0006-291X. PMID 6.
  7. ^ Anderson, T. R.; Slotkin, T. A. (15 August 1975). "Maturation of the adrenal medulla--IV. Effects of morphine". Biochemical Pharmacology. 24 (16): 1469–1474. doi:10.1016/0006-2952(75)90020-9. ISSN 1873-2968. PMID 7.
  8. ^ Moroi, K.; Sato, T. (15 August 1975). "Comparison between procaine and isocarboxazid metabolism in vitro by a liver microsomal amidase-esterase". Biochemical Pharmacology. 24 (16): 1517–1521. doi:10.1016/0006-2952(75)90029-5. ISSN 1873-2968. PMID 8.
  9. ^ Marniemi, J.; Parkki, M. G. (1 September 1975). "Radiochemical assay of glutathione S-epoxide transferase and its enhancement by phenobarbital in rat liver in vivo". Biochemical Pharmacology. 24 (17): 1569–1572. doi:10.1016/0006-2952(75)90080-5. ISSN 0006-2952. PMID 9.
  10. ^ Schmoldt, A.; Benthe, H. F.; Haberland, G. (1 September 1975). "Digitoxin metabolism by rat liver microsomes". Biochemical Pharmacology. 24 (17): 1639–1641. ISSN 1873-2968. PMID 10.
  11. ^ Lefkowitz, R. J. (15 September 1975). "Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists". Biochemical Pharmacology. 24 (18): 1651–1658. doi:10.1016/0006-2952(75)90001-5. ISSN 0006-2952. PMID 11.
  12. ^ Stein, J. M. (15 September 1975). "The effect of adrenaline and of alpha- and beta-adrenergic blocking agents on ATP concentration and on incorporation of 32Pi into ATP in rat fat cells". Biochemical Pharmacology. 24 (18): 1659–1662. doi:10.1016/0006-2952(75)90002-7. ISSN 0006-2952. PMID 12.
  13. ^ Järvisalo, J.; Saris, N. E. (15 September 1975). "Action of propranolol on mitochondrial functions--effects on energized ion fluxes in the presence of valinomycin". Biochemical Pharmacology. 24 (18): 1701–1705. doi:10.1016/0006-2952(75)90009-x. ISSN 0006-2952. PMID 13.
  14. ^ Bhagwat, V. M.; Ramachandran, B. V. (15 September 1975). "Malathion A and B esterases of mouse liver-I". Biochemical Pharmacology. 24 (18): 1713–1717. doi:10.1016/0006-2952(75)90011-8. ISSN 0006-2952. PMID 14.
  15. ^ Akamatsu, N.; Nakajima, H.; Ono, M.; Miura, Y. (15 September 1975). "Increase in acetyl CoA synthetase activity after phenobarbital treatment". Biochemical Pharmacology. 24 (18): 1725–1727. doi:10.1016/0006-2952(75)90013-1. ISSN 0006-2952. PMID 15.
  16. ^ Turner, A. J.; Hick, P. E. (15 September 1975). "Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines". Biochemical Pharmacology. 24 (18): 1731–1733. doi:10.1016/0006-2952(75)90016-7. ISSN 0006-2952. PMID 16.
  17. ^ Renaud, B.; Buda, M.; Lewis, B. D.; Pujol, J. F. (15 September 1975). "Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat". Biochemical Pharmacology. 24 (18): 1739–1742. doi:10.1016/0006-2952(75)90018-0. ISSN 0006-2952. PMID 17.
  18. ^ Ris, M. M.; Deitrich, R. A.; Von Wartburg, J. P. (15 October 1975). "Inhibition of aldehyde reductase isoenzymes in human and rat brain". Biochemical Pharmacology. 24 (20): 1865–1869. doi:10.1016/0006-2952(75)90405-0. ISSN 0006-2952. PMID 18.